October 05, 2010 09:21 ET

Grupo Int'l Inc. Continues to Expand by Opening Its 15th Store in La Paz, Baja Calif.

SAN DIEGO, CA--(Marketwire - October 5, 2010) -  Grupo International Inc. (formally, "HIV-VAC, Inc.") current stock symbol (PINKSHEETS: HIVV) -- President Ramon Richard announced today that Grupo International Inc. will open its 15th store this year in La Paz, Baja Mexico. This store location will also serve as a new hub warehouse store for the Region. The Company expects to open 4 more stores in and around La Paz over the next six months.

President Richard stated that when a store is opened in a new region the company usually receives additional benefits and sales generated from these openings for its other divisions. Last month, Grupo International opened a store in Hub warehouse Ensenada, which it feels will be able carry products for the large agriculture industry. 

Grupo International Inc. operates two divisions: HIV-VAC Pharmaceutical and the "Richard y Lange Division" which operates under the names of "RiMart," which presently operates 14 tool retail stores throughout Baja California. The Company plans to open an additional 6 stores by the first quarter of "2011." Other divisions are: "GR Construction," specializing in large industrial projects, "Block GRYLSA" which operates block manufacturing facilities, and GRYLSA's, a raw materials division that mines commercial grade sand located near the border of the State of California and Baja California. 

For more information please check the Company's information or web site below.

Safe Harbor: The information contained in this press release, including any "forward looking" statements within the meaning of section 27A of the securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the Company's Annual Report on Form 10-KSB and other publicly available information regarding the Company, copies of which are available from the Company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business and such statements, including risks and uncertainties related to that are unpredictable and outside of the influence and/or control of the Company. In particular, these risks and uncertainties include, without limitation: that third parties may be successful in challenging the patent issued; that granted claims may be held invalid or interpreted differently by a court of law; that other patents will issue that will block the Company from commercializing the technology covered by the patents; and that the benefits that Company believes can be derived from the patented technology will not be realized due to difficulties encountered in the long and expensive process of the development of new technologies and the cost and uncertainty in obtaining regulatory approval for products based on these technologies. In addition, there are many other risks and uncertainties inherent in the development of the Company's products, including the risk of not obtaining regulatory approval for a variety of reasons and the risk of adverse side effects in humans. Other risks relating to Company are detailed from time to time in documents filed by Company with the SEC.

Contact Information

    HIV-VAC, Inc.
    Kevin W. Murray
    12 Harben Court
    Collingwood, Ontario, Canada L9Y 4L8
    Tel: (705) 444-6317

    Web Site:
    Investor Relations:
    Contact Number: 702-952-3998